These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 18974783)

  • 41. Birt-Hogg-Dubé syndrome, a genodermatosis that increases risk for renal carcinoma.
    Schmidt LS
    Curr Mol Med; 2004 Dec; 4(8):877-85. PubMed ID: 15579035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
    Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
    Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pulmonary cysts of Birt-Hogg-Dubé syndrome: a clinicopathologic and immunohistochemical study of 9 families.
    Furuya M; Tanaka R; Koga S; Yatabe Y; Gotoda H; Takagi S; Hsu YH; Fujii T; Okada A; Kuroda N; Moritani S; Mizuno H; Nagashima Y; Nagahama K; Hiroshima K; Yoshino I; Nomura F; Aoki I; Nakatani Y
    Am J Surg Pathol; 2012 Apr; 36(4):589-600. PubMed ID: 22441547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
    Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
    Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.
    Hasumi H; Baba M; Hasumi Y; Huang Y; Oh H; Hughes RM; Klein ME; Takikita S; Nagashima K; Schmidt LS; Linehan WM
    J Natl Cancer Inst; 2012 Nov; 104(22):1750-64. PubMed ID: 23150719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.
    Schmidt LS
    Fam Cancer; 2013 Sep; 12(3):357-64. PubMed ID: 23108783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Birt-Hogg-Dubé (BHD) gene mutations in human gastric cancer with high frequency microsatellite instability.
    Jiang W; Fujii H; Matsumoto T; Ohtsuji N; Tsurumaru M; Hino O
    Cancer Lett; 2007 Apr; 248(1):103-11. PubMed ID: 16870330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathology of Birt-Hogg-Dubé syndrome: A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review.
    Furuya M; Nakatani Y
    Pathol Int; 2019 Jan; 69(1):1-12. PubMed ID: 30632664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Folliculin, the product of the Birt-Hogg-Dube tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion.
    Medvetz DA; Khabibullin D; Hariharan V; Ongusaha PP; Goncharova EA; Schlechter T; Darling TN; Hofmann I; Krymskaya VP; Liao JK; Huang H; Henske EP
    PLoS One; 2012; 7(11):e47842. PubMed ID: 23139756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.
    Hartman TR; Nicolas E; Klein-Szanto A; Al-Saleem T; Cash TP; Simon MC; Henske EP
    Oncogene; 2009 Apr; 28(13):1594-604. PubMed ID: 19234517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and characterization of Birt-Hogg-Dubé associated renal carcinoma.
    Murakami T; Sano F; Huang Y; Komiya A; Baba M; Osada Y; Nagashima Y; Kondo K; Nakaigawa N; Miura T; Kubota Y; Yao M; Kishida T
    J Pathol; 2007 Apr; 211(5):524-531. PubMed ID: 17323425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Birt-Hogg-Dubé syndrome: clinical and genetic studies of 20 families.
    Leter EM; Koopmans AK; Gille JJ; van Os TA; Vittoz GG; David EF; Jaspars EH; Postmus PE; van Moorselaar RJ; Craanen ME; Starink TM; Menko FH
    J Invest Dermatol; 2008 Jan; 128(1):45-9. PubMed ID: 17611575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spontaneous pneumothorax due to Birt-Hogg-Dube syndrome in a Chinese family.
    So SY
    Respirology; 2009 Jul; 14(5):775-6. PubMed ID: 19659657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Birt-Hogg-Dubé syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2.
    Khoo SK; Bradley M; Wong FK; Hedblad MA; Nordenskjöld M; Teh BT
    Oncogene; 2001 Aug; 20(37):5239-42. PubMed ID: 11526515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development.
    Baba M; Keller JR; Sun HW; Resch W; Kuchen S; Suh HC; Hasumi H; Hasumi Y; Kieffer-Kwon KR; Gonzalez CG; Hughes RM; Klein ME; Oh HF; Bible P; Southon E; Tessarollo L; Schmidt LS; Linehan WM; Casellas R
    Blood; 2012 Aug; 120(6):1254-61. PubMed ID: 22709692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transgenic rescue from embryonic lethality and renal carcinogenesis in the Nihon rat model by introduction of a wild-type Bhd gene.
    Togashi Y; Kobayashi T; Momose S; Ueda M; Okimoto K; Hino O
    Oncogene; 2006 May; 25(20):2885-9. PubMed ID: 16369488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations.
    Adley BP; Smith ND; Nayar R; Yang XJ
    Arch Pathol Lab Med; 2006 Dec; 130(12):1865-70. PubMed ID: 17149965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Birt-Hogg-Dubé syndrome in a patient with localized fibrofolliculomas and a novel mutation in the FLCN gene.
    Alonso-González J; Rodríguez-Pazos L; Fernández-Redondo V; Vega-Gliemmo A; Toribio J
    Int J Dermatol; 2011 Aug; 50(8):968-71. PubMed ID: 21781069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FLCN gene-mutated renal cell neoplasms: mother and daughter cases with a novel germline mutation.
    Nagashima Y; Furuya M; Gotohda H; Takagi S; Hes O; Michal M; Grossmann P; Tanaka R; Nakatani Y; Kuroda N
    Int J Urol; 2012 May; 19(5):468-70. PubMed ID: 22211584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of apolipoproteinA1 reduction in the polycystic kidney by proteomics analysis of the Mxi1-deficient mouse.
    Yoo KH; Kim YN; Lee MJ; Seong JK; Park JH
    Proteomics; 2009 Aug; 9(15):3824-32. PubMed ID: 19637234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.